In an open controlled trial, 100 patients with vaginitis were treated with clotrimazole vaginal tablets. Ninety-four patients were infected with Candida and six patients with trichomonas. Therapy was continued for six days in 80% of patients and for up to twelve days in 18%. Judged on clinical and mycological results at the end of therapy, 57 patients were cured and 25 patients improved (90·1% effective). No patients were made worse and side-effects were minimal.
The trial showed that clotrimazole was a fast, safe and effective treatment for candida vaginitis. Insufficient patients had trichomonas vaginitis for a clear conclusion to be drawn.
Get full access to this article
View all access options for this article.
References
1.
FredrikssonT (1972) Topical treatment with Bay b 5097. A new broad spectrum anti-mycotic agent. British Journal of Dermatology86, 628–630
2.
HirschHASzalmayGDedesM (1971) Treatment of genital mycoses with clotrimazole (Bay b 5097). VII International Congress of Chemotherapy, Prague
3.
HoltRJNewmanRL (1972) Laboratory assessment of the antimycotic drug, clotrimazole. Journal of Clinical Pathology25, 1089–1097
4.
PlempelMBartmannKBuchelKHRegelE (1969) Experimentelle Befunde uber ein neues, oral wirkendes Antimykotikum mit breitem Wirkungsspektrum. Deutsche medizinische Wochenschrift94, 1356–1364
5.
WeutaH (1972a) Clotrimazole cream and solution—clinical investigation in an open study. Arzneimittel Forschung15, 126–132
6.
WeutaH (1972b) Clotrimazole vaginal tablets—clinical investigation in an open study. Arzneimittel Forschung15, 121–126
